DE69012901D1 - Hämoregulierende Peptide. - Google Patents

Hämoregulierende Peptide.

Info

Publication number
DE69012901D1
DE69012901D1 DE69012901T DE69012901T DE69012901D1 DE 69012901 D1 DE69012901 D1 DE 69012901D1 DE 69012901 T DE69012901 T DE 69012901T DE 69012901 T DE69012901 T DE 69012901T DE 69012901 D1 DE69012901 D1 DE 69012901D1
Authority
DE
Germany
Prior art keywords
hemoregulating
peptides
compounds
chem
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69012901T
Other languages
English (en)
Other versions
DE69012901T2 (de
Inventor
Pradip Kumar Bhatnagar
William Francis Huffman
James Edward Talmadge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
SmithKline Beecham Corp
Original Assignee
GlaxoSmithKline LLC
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline LLC, SmithKline Beecham Corp filed Critical GlaxoSmithKline LLC
Application granted granted Critical
Publication of DE69012901D1 publication Critical patent/DE69012901D1/de
Publication of DE69012901T2 publication Critical patent/DE69012901T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69012901T 1989-07-14 1990-07-12 Hämoregulierende Peptide. Expired - Fee Related DE69012901T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38057889A 1989-07-14 1989-07-14

Publications (2)

Publication Number Publication Date
DE69012901D1 true DE69012901D1 (de) 1994-11-03
DE69012901T2 DE69012901T2 (de) 1995-02-16

Family

ID=23501712

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69012901T Expired - Fee Related DE69012901T2 (de) 1989-07-14 1990-07-12 Hämoregulierende Peptide.

Country Status (25)

Country Link
EP (1) EP0408371B1 (de)
JP (1) JP2638666B2 (de)
KR (1) KR910002899A (de)
CN (1) CN1034663C (de)
AT (1) ATE112289T1 (de)
AU (1) AU638468B2 (de)
CA (1) CA2020838C (de)
DE (1) DE69012901T2 (de)
DK (1) DK0408371T3 (de)
ES (1) ES2064642T3 (de)
FI (1) FI94354C (de)
HK (1) HK1004554A1 (de)
HU (1) HU206889B (de)
IE (1) IE65533B1 (de)
IL (1) IL95012A (de)
MA (1) MA21902A1 (de)
MX (1) MX21581A (de)
MY (1) MY106352A (de)
NO (1) NO177713C (de)
NZ (1) NZ234501A (de)
PH (1) PH30055A (de)
PL (2) PL165133B1 (de)
PT (1) PT94702B (de)
ZA (1) ZA905505B (de)
ZW (1) ZW11290A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW222280B (de) * 1991-11-26 1994-04-11 Smithkline Beecham Corp
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
GB9211668D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
ATE172204T1 (de) * 1992-06-02 1998-10-15 Nycomed Imaging As Doppelsträngige peptidverbindungen mit hämoregulatorischer aktivität
GB9211677D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GB9211674D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
ES2052447B1 (es) * 1992-12-14 1995-01-16 Smithkline Beecham Corp Peptidos hemorreguladores.
DE69421698T2 (de) * 1993-05-14 2000-03-09 Mallinckrodt, Inc. Die vorstufe eines liganden zum einbau in peptide
ES2210255T3 (es) * 1993-06-08 2004-07-01 Smithkline Beecham Corporation Metodos para mejorar la actividad biologica de quimiocinas.
GB9314200D0 (en) * 1993-07-09 1993-08-18 Hafslund Nycomed As Peptide compounds
EP0725651B1 (de) * 1993-10-29 1999-08-11 Smithkline Beecham Corporation Blutregulierende peptide
GB9324691D0 (en) * 1993-12-01 1994-01-19 Hafslund Nycomed As Peptide compounds
US5714469A (en) * 1994-09-01 1998-02-03 Smithkline Beecham Corporation Method of treating sepsis
KR19990082424A (ko) * 1996-02-13 1999-11-25 이.에이치. 리링크 세린 프로테아제 억제제
IL120310A (en) 1996-03-01 2002-02-10 Akzo Nobel Nv Serine protease inhibitors and pharmaceuticals containing them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2860734D1 (en) * 1977-06-08 1981-09-03 Merck & Co Inc Somatostatin analogs, process for their preparation and pharmaceutical compositions containing them
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds

Also Published As

Publication number Publication date
AU5901490A (en) 1991-01-17
MX21581A (es) 1994-01-31
JP2638666B2 (ja) 1997-08-06
JPH0356498A (ja) 1991-03-12
HUT55034A (en) 1991-04-29
MY106352A (en) 1995-05-30
ATE112289T1 (de) 1994-10-15
EP0408371A1 (de) 1991-01-16
ZA905505B (en) 1991-04-24
FI94354B (fi) 1995-05-15
KR910002899A (ko) 1991-02-26
PT94702A (pt) 1991-03-20
PL166004B1 (pl) 1995-03-31
ZW11290A1 (en) 1990-10-31
NO903148L (no) 1991-01-15
CN1054773A (zh) 1991-09-25
NZ234501A (en) 1991-08-27
MA21902A1 (fr) 1991-04-01
NO903148D0 (no) 1990-07-13
PL286043A1 (en) 1991-03-25
IE902547A1 (en) 1991-02-27
EP0408371B1 (de) 1994-09-28
HU904201D0 (en) 1990-12-28
PT94702B (pt) 1997-04-30
NO177713B (no) 1995-07-31
CA2020838A1 (en) 1991-01-15
HK1004554A1 (en) 1998-11-27
IE65533B1 (en) 1995-11-01
IL95012A0 (en) 1991-06-10
CN1034663C (zh) 1997-04-23
DE69012901T2 (de) 1995-02-16
FI94354C (fi) 1995-08-25
FI903571A0 (fi) 1990-07-13
PH30055A (en) 1996-11-08
ES2064642T3 (es) 1995-02-01
NO177713C (no) 1995-11-08
PL165133B1 (pl) 1994-11-30
HU206889B (en) 1993-01-28
IL95012A (en) 1995-03-15
AU638468B2 (en) 1993-07-01
CA2020838C (en) 2000-05-02
DK0408371T3 (da) 1996-12-16

Similar Documents

Publication Publication Date Title
ATE112289T1 (de) Hämoregulierende peptide.
IL86439A0 (en) Cyclic anticoagulant peptides
EP0291982A3 (en) Cyclic anticoagulant peptides
ATE201693T1 (de) Hämoregulierende peptide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee